论文部分内容阅读
目的:探讨硫酸镁治疗妊高症的临床疗效。方法:收集2014年1月-2014年12月我院诊断为妊高症的患者作为本次研究对象,按随机号码表法分为2组,50例研究组和50例对照组,研究组接受硫酸镁+拉贝洛尔+尼群地平降压,对照组接受拉贝洛尔+尼群地平降压。记录患者治疗前后收缩压和舒张压的变化及两组新生儿APGAR评分。结果:(1)研究组和对照组治疗前收缩压和舒张压差异无统计学意义(P>0.05);研究组和对照组治疗后收缩压和舒张压差异有统计学意义(P<0.05)。(2)研究组和对照组新生儿Apgar评分分别为9.6±0.3分、7.9±2.4分,差异有统计学意义(P<0.05)。结论:本次研究认为硫酸镁配合降压药物能有效控制妊高症产妇血压水平,改善新生儿Apgar评分,值得临床推广。
Objective: To investigate the clinical efficacy of magnesium sulfate in the treatment of pregnancy induced hypertension. Methods: Patients who were diagnosed with pregnancy-induced hypertension in our hospital from January 2014 to December 2014 were enrolled in this study. Patients were divided into 2 groups, 50 study groups and 50 control groups by random number table. The study group received Magnesium sulfate + labetalol + nitrendipine, and control group received labetalol + nitrendipine. The changes of systolic and diastolic blood pressure before and after treatment were recorded and the APGAR scores of neonates in both groups were recorded. Results: (1) There was no significant difference in systolic and diastolic blood pressure before and after treatment between study group and control group (P> 0.05). There was significant difference in systolic pressure and diastolic pressure between study group and control group after treatment (P <0.05) . (2) Apgar scores of neonates in study group and control group were 9.6 ± 0.3 and 7.9 ± 2.4 respectively, the difference was statistically significant (P <0.05). Conclusion: This study suggests that magnesium sulfate combined with antihypertensive drugs can effectively control the blood pressure of pregnant women with hypertension and improve Apgar score, which is worthy of clinical promotion.